U.S. stock futures were mixed this morning, with the S&P 500 futures falling around 0.1% on Monday.
Shares of Fabrinet FN fell sharply in pre-market trading following fourth-quarter result s.
Fabrinet reported better-than-expected fourth-quarter financial results for fiscal 2025 on Monday. Fabrinet expects fiscal first-quarter revenue to be in the range of $910 million to $950 million, versus estimates of $916.72 million. The company expects first-quarter adjusted earnings to be in the range of $2.75 to $2.90 per share, versus estimates of $2.74 per share.
Fabrinet shares dipped 9.7% to $295.54 in the pre-market trading session.
Trending Investment Opportunities Advertisement Arrived Buy shares of homes and vacation rentals for as little as $100. Get Started Interactive Brokers Trade global markets with low costs and pro-level tools at Interactive Brokers. Get Started Range Range delivers AI-powered wealth management at a fraction of the cost. Get Started Rocket HELOC Get a HELOC with mid-600s credit — borrow and repay on repeat. Get Started Pacaso Join 10,000+ investors betting on Pacaso’s global expansion at $2.90 per share. Get Started Worthy Bonds Earn 7% fixed interest with Worthy Bonds — start investing with just $10. Get Started NinjaTrader NinjaTrader gives you futures access with low day-trading margins. Get Started IRA Financial Invest your IRA or 401(k) in real estate, crypto, and more with IRA Financial. Get Started Acorns Grow wealth effortlessly — Acorns invests your spare change automatically. Get Started SmartAsset Find a vetted financial advisor near you in minutes with SmartAsset's free tool. Get StartedHere are some other stocks moving lower in pre-market trading.
Xunlei Limited XNET declined 8.4% to $8.05 in pre-market trading after jumping around 38% on Monday. Precigen, Inc. PGEN dipped 5.8% to $2.78 in pre-market trading. Precigen recently announced the FDA has approved PAPZIMEOS. Adecoagro S.A. AGRO fell 4.5% to $8.79 in pre-market trading after reporting downbeat quarterly results. Immatics NV IMTX shares fell 3.9% to $5.97 in pre-market trading. Tonix Pharmaceuticals Holding Corp TNXP fell 3.9% to $38.51 in pre-market trading. On Friday, the U.S. Food and Drug Administration (FDA) approved Tonix Pharmaceuticals' Tonmya (cyclobenzaprine HCl sublingual tablets) for fibromyalgia in adults.Now Read This:
Wall Street’s Most Accurate Analysts Spotlight On 3 Financial Stocks Delivering High-Dividend YieldsPhoto via Shutterstock
Loading... Loading... AGRO Adecoagro SA $8.70 -5.43%Stock Score Locked: Edge Members Only
Benzinga Rankings give you vital metrics on any stock – anytime.
Unlock RankingsEdge Rankings
Momentum 22.65 Growth 63.53 Quality N/A Value 85.59Price Trend
Short Medium Long Overview FN Fabrinet $294.34 -10.0% IMTX Immatics NV $5.97 -3.86% PGEN Precigen Inc $2.77 -6.10% TNXP Tonix Pharmaceuticals Holding Corp $38.50 -3.92% XNET Xunlei Ltd $8.12 -7.62% Market News and Data brought to you by Benzinga APIs© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In: News Pre-Market Outlook Markets Movers Trading Ideas big losers Premarket Movers